Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-04-001008
Filing Date
2004-03-09
Accepted
2004-03-09 12:54:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 d469393_13g-a.txt SC 13G/A 19307
  Complete submission text file 0000919574-04-001008.txt   21152
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 04656674
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
DEERFIELD CAPITAL LP ET AL (Filed by) CIK: 0001010823 (see all company filings)